Assignee
NOORIK BIOPHARMACEUTICALS AG
CH·3 granted patents·1 pending application·0 citations·filing 2017–2023
Top patents by PatentIndex Score
4 records- 0169US2023233454A1Ambrisentan for use in the treatment of acute renal failureNOORIK BIOPHARMACEUTICALS AG·Filed 2023·Application pending·0 cites
- 0259US11642307B2Ambrisentan for use in the treatment of acute renal failureNOORIK BIOPHARMACEUTICALS AG·Filed 2020·Granted May 9, 2023·0 cites·16 claims
- 0358US10870021B2Ambrisentan for use in the treatment of acute renal failureNOORIK BIOPHARMACEUTICALS AG·Filed 2017·Granted Dec 22, 2020·0 cites·20 claims
- 0453US11883400B2Treatment of portal hypertension and cirrhosisNOORIK BIOPHARMACEUTICALS AG·Filed 2019·Granted Jan 30, 2024·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when NOORIK BIOPHARMACEUTICALS AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →